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Ablation for atrial fibrillation: are cures really
achieved, 1940
Catheter ablation of atrial fibrillation: what is the
best technique for achieving a high cure rate
with acceptable risk?, 2054
Characteristics of virtual unipolar electrograms for
detecting isthmus block during radiofrequency
ablation of typical atrial flutter, 2300
Combining ablation of atrial fibrillation with atrial
flutter: are we there yet?, 2063
Endocardial and epicardial radiofrequency ablation
of ventricular tachycardia associated with
dilated cardiomyopathy, 1834
Functional characterization of the crista terminalis
in patients with atrial flutter: implications for
radiofrequency ablation, 1639
Left atrial thrombus associated with ablation for
atrial fibrillation: identification with
intracardiac echocardiography, 1861
Mode of initiation and ablation of ventricular
fibrillation storms in patients with ischemic
cardiomyopathy, 1715
New approach for catheter ablation of atrial
fibrillation: mapping of the
electrophysiological substrate, 2044
Radiofrequency catheter ablation of type 1 atrial
flutter using large-tip 8- or 10-mm electrode
catheters and a high-output radiofrequency
energy generator, 1466
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711
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the ACC meet its members’ needs?
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organizational plans and decisions, 2361
President’s page: strengthening our house of
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Actin polymerization
Release of soluble CD40 ligand from platelets is
regulated by GP IIb/IIIa and actin
polymerization, 2319
Acute coronary syndromes
Administration of eptifibatide to acute coronary
syndrome patients receiving enoxaparin or
unfractionated heparin, 966
Aspirin dose and six-month outcome after an acute
coronary syndrome, 972
Clopidogrel inhibits platelet-leukocyte interactions
and TRAP-induced platelet activation in
patients with an acute coronary syndrome,
1982
Dose finding study of fondaparinux in patients with
non ST-segment elevation acute coronary
syndromes: the PENTUA study, 2183
Implication of different cardiac troponin I levels for
clinical outcomes and prognosis of acute chest
pain patients, 958
Importance of increasing age on the presentation
and outcome of acute coronary syndromes in
elderly patients, 346
Severe ostial saphenous vein graft disease leading to
acute coronary syndromes following proximal
aorto-saphenous anastomoses with the
Symmetry Bypass Connector device, 133
Year in interventional cardiology, 875
Acute myocardial infarction
See Myocardial infarction
Adamantiades-Behcet’s disease
Aortic elastic properties and left ventricular diastolic
function in patients with Adamantiades-
Behcet’s disease, 1075
Adiponectin I164T
Adiponectin I164T mutation is associated with the
metabolic syndrome and coronary artery
disease, 1195
Adiposity
Exercise training normalizes vascular dysfunction
and improves central adiposity in obese
adolescents, 1823
Adolescents
Exercise training normalizes vascular dysfunction
and improves central adiposity in obese
adolescents, 1823
Long-term outcome (up to 15 years) of balloon
angioplasty of discrete native coarctation of
the aorta in adolescents and adults, 1062
Adrenergic stimulation
Roles of adrenergic and cholinergic stimulation in
spontaneous atrial fibrillation in dogs, 483
African Americans
See also Race
Cardiovascular risk reduction in hypertensive black
patients with left ventricular hypertrophy,
1047
Heart rate-corrected QT interval prolongation
predicts risk of coronary heart disease in black
and white middle-aged men and women, 565
High lipoprotein(a) levels and small
apolipoprotein(a) sizes are associated with
endothelial dysfunction in a multiethnic
cohort, 1828
Racial variation in the prevalence of atrial
fibrillation among patients with heart failure,
429
What we’re talking about when we talk about race
(editorial), 436
Age
See also Elderly
Influence of age, gender, and race on the prevalence
of depression in heart failure patients, 1542
Akinesia
Akinesia becoming dyskinesia after exercise testing:
prevalence and relationship to clinical
outcome, 599
Alcohol
Alcohol consumption and prognosis in patients
with left ventricular systolic dysfunction after
a myocardial infarction, 2015
Aldosterone
Acute aldosterone antagonism improves cardiac
vagal control in humans, 1270
Aldosterone synthase gene
Association between aldosterone synthase
(CYP11B2) polymorphism and left ventricular
mass in human essential hypertension, 265
Allograft vasculopathy
Impact of mode of donor brain death on cardiac
allograft vasculopathy, 806
Palliation of allograft vasculopathy with
transluminal angioplasty: a decade of
experience, 1973
Allografts
Outcomes in cardiac transplant recipients using
allografts from older donors versus mortality
on the transplant waiting list, 1553
Amlodipine
Comparative effects of valsartan versus amlodipine
on left ventricular mass and reactive oxygen
species formation by monocytes in
hypertensive patients with left ventricular
hypertrophy, 2116
Amplatzer septal occluder
Device closure of muscular ventricular septal defects
using the Amplatzer muscular ventricular
septal defect occluder, 1257
Reversible atrioventricular block associated with
closure of atrial septal defects using the
Amplatzer device, 1677
Amyloidosis
Noninvasive diagnosis of biopsy-proven cardiac
amyloidosis, 410
Anastomoses
Severe ostial saphenous vein graft disease leading to
acute coronary syndromes following proximal
aorto-saphenous anastomoses with the
Symmetry Bypass Connector device, 133
Angina pectoris
Angina pectoris prior to myocardial infarction
protects against subsequent left ventricular
remodeling, 1511
Anti-ischemic effects and long-term survival during
ranolazine monotherapy in patients with
chronic severe angina, 1375
Impaired intravascular triglyceride lipolysis
constitutes a marker of clinical outcome in
patients with stable angina under secondary
prevention treatment: a long-term follow-up,
2225
Multislice spiral CT coronary angiography in
patients with stable angina pectoris, 2265
Angiogenesis
Novel application of myocardial contrast
echocardiography to evaluate angiogenesis by
autologous bone marrow cell transplantation
in chronic ischemic pig model, 1299
Powerful and controllable angiogenesis by using
gene-modified cells expressing human
hepatocyte growth factor and thymidine
kinase, 1915
Angiogenic cells
Exercise acutely increases circulating endothelial
progenitor cells and monocyte/macrophage
derived angiogenic cells, 2314
Angiography
See also Coronary angiography; Magnetic resonance
angiography, 831
Diagnostic accuracy of multidetector computed
tomography coronary angiography in patients
with angiographically proven coronary artery
disease, 831
Do we have a gold standard yet? (editorial), 662
Magnetic resonance angiography is equivalent to
x-ray coronary angiography for the evaluation
of coronary arteries in Kawasaki disease, 649
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Angioplasty
See also Balloon angioplasty; Percutaneous
transluminal coronary angioplasty; Primary
angioplasty
Impact of delays to cardiac surgery after failed
angioplasty and stenting, 337
Importance of mitral regurgitation in patients
undergoing percutaneous coronary
intervention for acute myocardial infarction,
1368
Preprocedural TIMI flow and mortality in patients
with acute myocardial infarction treated by
primary angioplasty, 1363
Primary angioplasty in acute myocardial infarction
at hospitals with no surgery on-site (PAMI
No SOS) versus transfer to surgical centers
for primary angioplasty, 1943
Surgery, angioplasty, or medical therapy for
symptomatic multivessel coronary artery
disease (editorial), 1752
Angiopoietin-1
Plasma angiopoietin-1, angiopoietin-2, and
angiopoietin receptor tie-2 levels in congestive
heart failure, 423
Angiopoietin-2
Plasma angiopoietin-1, angiopoietin-2, and
angiopoietin receptor tie-2 levels in congestive
heart failure, 423
Angiopoietin receptor tie-2
Plasma angiopoietin-1, angiopoietin-2, and
angiopoietin receptor tie-2 levels in congestive
heart failure, 423
Angiotensin II
Cerebroprotection mediated by angiotensin II, 1343
Osteopontin modulates angiotensin II-induced
fibrosis in the intact murine heart, 1698
Angiotensin II receptors
Angiotensin II receptors from peritransplantation
through first-year post-transplantation and the
risk of transplant coronary artery disease, 1565
Expression of angiotensin II receptors in human
left and right atrial tissue in atrial fibrillation
with and without underlying mitral valve
disease (letter), 2363
Role of angiotensin II type 2 receptors and kinins
in the cardioprotective effect of angiotensin II
type 1 receptor antagonists in rats with heart
failure, 1473
Angiotensin receptor blocker
Angiotensin receptor blockade improves myocardial
beta-adrenergic receptor signaling in postinfarc-
tion left ventricular remodeling, 125
Angiotensin-converting enzyme inhibitors
Angiotensin-converting enzyme inhibitors, beta-
blockers, and mortality in systolic heart failure
(letter), 1333
Mechanism(s) of selective systolic blood pressure
reduction after low-dose combination of
perindopril/indapamide in hypertensive
subjects: comparison with atenolol, 92
Outpatient utilization of angiotensin converting
enzyme inhibitors among heart failure patients
after hospital discharge, 2036
Animal models
See also Porcine models; Murine models
Autoimmunity against the second extracellular loop
of the beta1-adrenergic receptors induces early
afterdepolarization and decreases in K-channel
density in rabbits, 1090
Long-term subthreshold electrical stimulation of
the left stellate ganglion and a canine model
of sudden cardiac death, 858
Roles of adrenergic and cholinergic stimulation in
spontaneous atrial fibrillation in dogs, 483
Anterior fat pad
Preservation of the anterior fat pad paradoxically
decreases the incidence of postoperative atrial
fibrillation in humans, 994
Antiarrhythmic drugs
Azimilide decreases recurrent ventricular
tachyarrhythmias in patients with implantable
cardioverter defibrillators, 39
Filling the need for new antiarrhythmic drugs to
prevent shocks from implantable cardioverter
defibrillators (editorial), 44
Anticoagulation
See also Aspirin; Heparin
Comparing the guidelines: anticoagulation therapy
to optimize stroke prevention in patients with
atrial fibrillation, 929
Antioxidants
Long-term effect of combined vitamins E and C on
coronary and peripheral endothelial function,
629
Aortic dissection
Characterizing the young patient with aortic
dissection: from the International Registry of
Aortic Dissection (IRAD), 665
Aortic elastance
Aortic elastic properties and left ventricular diastolic
function in patients with Adamantiades-
Behcet’s disease, 1075
Aortic regurgitation
Year in valvular heart disease, 491
Aortic sclerosis
Adverse outcomes in aortic sclerosis is associated
with coronary artery disease and
inflammation, 169
Why is aortic sclerosis associated with adverse
clinical outcomes? (editorial), 176
Aortic stenosis
Early experience with percutaneous transcatheter
implantation of heart valve prosthesis for the
treatment of end-stage inoperable patients
with calcific aortic stenosis, 698
Magnetic resonance to assess the aortic valve area
in aortic stenosis (letter), 2148
Neoangiogenesis, T-lymphocyte infiltration, and
heat shock protein-60 are biological hallmarks
of an immunomediated inflammatory process
in end-stage calcified aortic valve stenosis,
1670
Aortic valve area
Magnetic resonance to assess the aortic valve area
in aortic stenosis (letter), 2148
Aorto-saphenous anastomoses
Severe ostial saphenous vein graft disease leading to
acute coronary syndromes following proximal
aorto-saphenous anastomoses with the
Symmetry Bypass Connector device, 133
Apolipoprotein(a)
High lipoprotein(a) levels and small
apolipoprotein(a) sizes are associated with
endothelial dysfunction in a multiethnic
cohort, 1828
Apoptosis
Human hibernating myocardium is jeopardized by
apoptotic and autophagic cell death, 2191
Long-term caspase inhibition ameliorates apoptosis,
reduces myocardial troponin-I cleavage,
protects left ventricular function, and
attenuates remodeling in rats with myocardial
infarction, 295
Arrhythmias
See also Atrial fibrillation; Atrial flutter; Ventricular
fibrillation; Ventricular tachycardia
Effects of biphasic waveform design on post-
resuscitation myocardial function, 1228
Gender differences in ventricular arrhythmias in
patients with coronary artery disease and
implantable cardioverter-defibrillators, 2293
Prognostic significance of exercise-induced atrial
arrhythmias, 1236
The year in congenital heart disease, 2132
Arrhythmogenic right ventricular
dysplasia/cardiomyopathy
Histologic findings in patients with clinical and
instrumental diagnosis of sporadic
arrhythmogenic right ventricular dysplasia,
2305
Implantable cardioverter-defibrillators in patients
with arrhythmogenic right ventricular
dysplasia/cardiomyopathy, 1843
Arterial duct
Stenting the neonatal arterial duct in duct-
dependent pulmonary circulation: new
techniques, better results, 107
Arterial hypertrophy
Prevalence of specific variant carotid geometric
patterns and incidence of cardiovascular events
in older persons, 187
Arteriography
Association of a pulsatile blood flow pattern on
coronary arteriography and short-term clinical
outcomes in acute myocardial infarction, 1170
Aspirin
Aspirin dose and six-month outcome after an acute
coronary syndrome, 972
Aspirin resistance: more than just a laboratory
curiosity (editorial), 1127
Aspirin resistance is associated with a high
incidence of myonecrosis after non-urgent
percutaneous coronary intervention despite
clopidogrel pretreatment, 1122
Case for an adverse interaction between aspirin and
non-steroidal anti-inflammatory drugs
(editorial), 991
Effects of nonselective non-aspirin non-steroidal
anti-inflammatory medications on the risk of
nonfatal myocardial infarction and their
interaction with aspirin, 985
Eptifibatide provides additional platelet inhibition
in non–ST-elevation myocardial infarction
patients already treated with aspirin and
clopidogrel, 162
Inhibition of platelet aggregation by aspirin
progressively decreases in long-term treated
patients, 979
Optimal suppression of thromboxane A2 formation
by aspirin during percutaneous transluminal
coronary angioplasty: no additional effect of a
selective cyclooxygenase-2 inhibitor, 526
Randomized trial of aspirin on the risk of embolic
events in patients with infective endocarditis
(letter), 1134
Therapeutic failure or resistance to aspirin (letter),
1332
Atenolol
Mechanism(s) of selective systolic blood pressure
reduction after low-dose combination of
perindopril/indapamide in hypertensive
subjects: comparison with atenolol, 92
Atherectomy
Meta-analysis of randomized trials of percutaneous
transluminal coronary angioplasty versus
atherectomy, cutting balloon atherotomy, or
laser angioplasty, 936
Atheroma
Intravascular ultrasound molecular imaging of
atheroma components in vivo, 453
Atherosclerosis
See also Coronary artery disease
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Accuracy of multidetector spiral computed
tomography in identifying and differentiating
the composition of coronary atherosclerotic
plaques, 1241
Assessment of coronary remodeling in stenotic and
nonstenotic coronary atherosclerotic lesions by
multidetector spiral computed tomography,
842
Decreased circulating Fas ligand in patients with
familial combined hyperlipidemia or carotid
atherosclerosis, 1188
Echolucent carotid plaques predict future coronary
events in patients with coronary artery disease,
1177
Plaque characterization: surrogate markers or the
real thing? (editorial), 1185
Selective peroxisomal proliferator-activated
receptor-gamma agonist has an additive effect
on plaque regression in combination with
simvastatin in experimental atherosclerosis,
464
Visualizing coronary atherosclerosis in vivo:
thinking big, imaging small (editorial), 461
Atria
See also Left atrium; Right atrium
Cardiac atria are chambers of active remodeling and
dynamic collagen turnover during evolving
heart failure, 68
Atrial ectopic tachycardia
Clinical course of atrial ectopic tachycardia is age-
dependent: results and treatment in children 3
or 3 years of age, 438
Atrial ectopy
Prognostic significance of exercise-induced atrial
arrhythmias, 1236
Atrial fibrillation
Ablation for atrial fibrillation: are cures really
achieved, 1940
Acute comparative effect of right and left
ventricular pacing in patients with permanent
atrial fibrillation, 234
Atrial Fibrillation Follow-up Investigation of
Rhythm Management (AFFIRM) study, 1201
Catheter ablation of atrial fibrillation: what is the
best technique for achieving a high cure rate
with acceptable risk?, 2054
Clinical significance of inducible atrial flutter
during pulmonary vein isolation in patients
with atrial fibrillation, 2057
Combining ablation of atrial fibrillation with atrial
flutter: are we there yet?, 2063
Comparing the guidelines: anticoagulation therapy
to optimize stroke prevention in patients with
atrial fibrillation, 929
Economic analysis of a transesophageal
echocardiography-guided approach to
cardioversion of patients with atrial
fibrillation, 1217
Economic implications of transesophageal
echocardiography-guided cardioversion of
atrial fibrillation (editorial), 1225
Effect of rate or rhythm control on quality of life in
persistent atrial fibrillation, 241
Efficacy of azimilide in the treatment of atrial
fibrillation in the presence of left ventricular
systolic dysfunction, 1211
Expression of angiotensin II receptors in human
left and right atrial tissue in atrial fibrillation
with and without underlying mitral valve
disease (letter), 2363
Impact of asymptomatic atrial fibrillation (editorial),
53
Left atrial thrombus associated with ablation for
atrial fibrillation: identification with
intracardiac echocardiography, 1861
Left ventricular mechanics during right ventricular
apical or left ventricular-based pacing in
patients with chronic atrial fibrillation after
atrioventricular junction ablation, 1013
Long-term risk of recurrent atrial fibrillation as
documented by an implantable monitoring
device, 47
Matrix metalloproteinase-9 contributes to human
atrial remodeling during atrial fibrillation, 818
Matrix metalloproteinases in atrial fibrillation
(letter), 152
New approach for catheter ablation of atrial
fibrillation: mapping of the
electrophysiological substrate, 2044
Postoperative atrial fibrillation: a billion-dollar
problem (editorial), 1001
Postoperative atrial fibrillation and mortality: do the
risks merit changes in clinical practice?
(editorial), 749
Postoperative atrial fibrillation and mortality after
coronary artery bypass surgery, 742
Preservation of the anterior fat pad paradoxically
decreases the incidence of postoperative atrial
fibrillation in humans, 994
Pulmonary vein isolation for atrial fibrillation in
low ejection fraction patients: the market is
growing (editorial), 1010
Pulmonary vein isolation for the treatment of atrial
fibrillation in patients with impaired systolic
function, 1004
Pulmonary veins in the substrate for atrial
fibrillation: the “venous wave” hypothesis
(editorial), 2290
Racial variation in the prevalence of atrial
fibrillation among patients with heart failure,
429
Relationship of interleukin-6 and C-reactive protein
to the prothrombotic state in chronic atrial
fibrillation, 2075
Roles of adrenergic and cholinergic stimulation in
spontaneous atrial fibrillation in dogs, 483
You only get so many heartbeats. . . (editorial),
1209
Atrial flutter
Characteristics of virtual unipolar electrograms for
detecting isthmus block during radiofrequency
ablation of typical atrial flutter, 2300
Clinical significance of inducible atrial flutter
during pulmonary vein isolation in patients
with atrial fibrillation, 2057
Combining ablation of atrial fibrillation with atrial
flutter: are we there yet?, 2063
Functional characterization of the crista terminalis
in patients with atrial flutter: implications for
radiofrequency ablation, 1639
Radiofrequency catheter ablation of type 1 atrial
flutter using large-tip 8- or 10-mm electrode
catheters and a high-output radiofrequency
energy generator, 1466
Atrial remodeling
Matrix metalloproteinase-9 contributes to human
atrial remodeling during atrial fibrillation, 818
Atrial septal defect
Incidence and clinical course of thrombus formation
on atrial septal defect and patent foramen
ovale closure devices in 1,000 consecutive
patients, 302
Transcatheter closure of atrial shunts (editorial),
310
Atrial septal defects
Determinants of cardiopulmonary functional
improvement after transcatheter atrial septal
defect closure in asymptomatic adults, 1886
Lessons from cardiopulmonary testing after device
closure of secundum atrial septal defects
(editorial), 1892
Reversible atrioventricular block associated with
closure of atrial septal defects using the
Amplatzer device, 1677
Atrioventricular block
Long QT syndrome in neonates, 826
Reversible atrioventricular block associated with
closure of atrial septal defects using the
Amplatzer device, 1677
Atrioventricular junction ablation
Left ventricular mechanics during right ventricular
apical or left ventricular-based pacing in
patients with chronic atrial fibrillation after
atrioventricular junction ablation, 1013
Autoimmunity
Autoimmunity against the second extracellular loop
of the beta1-adrenergic receptors induces early
afterdepolarization and decreases in K-channel
density in rabbits, 1090
Autophagic cell death
Human hibernating myocardium is jeopardized by
apoptotic and autophagic cell death, 2191
Azimilide
Azimilide decreases recurrent ventricular
tachyarrhythmias in patients with implantable
cardioverter defibrillators, 39
Efficacy of azimilide in the treatment of atrial
fibrillation in the presence of left ventricular
systolic dysfunction, 1211
Balloon angioplasty
Combined stenting versus balloon angioplasty in
small vessels, 1964
Heme oxygenase-1 genotype and restenosis after
balloon angioplasty: a novel protective factor,
950
Long-term outcome (up to 15 years) of balloon
angioplasty of discrete native coarctation of
the aorta in adolescents and adults, 1062
Randomized trial comparing myocardial salvage
achieved by coronary stenting versus balloon
angioplasty in patients with acute myocardial
infarction considered ineligible for reperfusion
therapy, 734
Baroreflex sensitivity
Acute aldosterone antagonism improves cardiac
vagal control in humans, 1270
Bayesian approaches
Prior convictions: Bayesian approaches to the
analysis and interpretation of clinical
megatrials, 1929
Beta-adrenergic receptor
Angiotensin receptor blockade improves myocardial
beta-adrenergic receptor signaling in postinfarc-
tion left ventricular remodeling, 125
Beta1-adrenergic receptors
Autoimmunity against the second extracellular loop
of the beta1-adrenergic receptors induces early
afterdepolarization and decreases in K-channel
density in rabbits, 1090
Beta-blockers
See also specific drug
Angiotensin-converting enzyme inhibitors, beta-
blockers, and mortality in systolic heart failure
(letter), 1333
Beta-blocker therapy and primary angioplasty
(editorial), 1788
Does beta-blocker therapy improve clinical
outcomes of acute myocardial infarction after
successful primary angioplasty?, 1773
Exercise release of cardiac natriuretic peptides is
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markedly enhanced when patients with
coronary artery disease are treated medically
by beta-blockers, 353
Impact of intravenous beta-blockade before primary
angioplasty on survival in patients undergoing
mechanical reperfusion therapy for acute
myocardial infarction, 1780
Influence of pretreatment systolic blood pressure on
the effect of carvedilol in patients with severe
chronic heart failure, 1423
Myocardial positron emission computed
tomographic images obtained with fluorine-18
fluoro-2-deoxyglucose predict the response to
idiopathic dilated cardiomyopathy patients to
beta-blockers, 224
Natriuretic peptides as predictors of non-sudden
and sudden cardiac death after acute
myocardial infarction in the beta-blocking era,
757
Predischarge initiation of carvedilol in patients
hospitalized for decompensated heart failure,
1534
Sustained ventricular tachycardia or fibrillation in
the cardiac catheterization laboratory among
patients receiving primary percutaneous
coronary intervention, 1765
17-Beta-estradiol– eluting stent
First human experience with the 17-beta-estradiol–
eluting stent, 1118
Biopsy
Noninvasive diagnosis of biopsy-proven cardiac
amyloidosis, 410
Biopyrrins
Urinary biopyrrins levels are elevated in relation to
severity of heart failure, 1880
Biphasic waveform
Effects of biphasic waveform design on post-
resuscitation myocardial function, 1228
Blood pressure
Blood pressure and the therapy of advanced heart
failure (editorial), 1430
Cardiology management improves secondary
prevention measures among patients with
coronary artery disease, 1517
Influence of pretreatment systolic blood pressure on
the effect of carvedilol in patients with severe
chronic heart failure, 1423
Mechanism(s) of selective systolic blood pressure
reduction after low-dose combination of
perindopril/indapamide in hypertensive
subjects: comparison with atenolol, 92
Bone marrow cell transplantation
Novel application of myocardial contrast
echocardiography to evaluate angiogenesis by
autologous bone marrow cell transplantation
in chronic ischemic pig model, 1299
Brachial artery reactivity
Relative importance of vascular structure and
function in predicting cardiovascular events,
616
Brain death
Impact of mode of donor brain death on cardiac
allograft vasculopathy, 806
Brain natriuretic peptide
Clinical significance of brain natriuretic peptide in
primary pulmonary hypertension, 764
Elevation of plasma brain natriuretic peptide is a
hallmark of diastolic heart failure independent
of ventricular hypertrophy, 55
Brugada syndrome
Hydroquinidine therapy in Brugada syndrome,
1853
B-type natriuretic peptide
B-type natriuretic peptide and peak exercise oxygen
consumption provide independent information
for risk stratification in patients with stable
congestive heart failure, 1584
Cost-effectiveness of screening with B-type
natriuretic peptide to identify patients with
reduced left ventricular ejection fraction, 1019
Obesity and suppressed B-type natriuretic peptide
levels in heart failure, 1590
Plasma B-type natriuretic peptide levels in systolic
heart failure, 416
Predischarge B-type natriuretic peptide assay for
identifying patients at high risk of re-
admission after decompensated heart failure,
635
Utility of B-type natriuretic peptide in predicting
postoperative complications and outcomes in
patients undergoing heart surgery, 1873
Bundle-branch block
Limitation of exercise tolerance in chronic heart
failure: distinct effects of left bundle-branch
block and coronary artery disease, 1524
Calcific aortic stenosis
Early experience with percutaneous transcatheter
implantation of heart valve prosthesis for the
treatment of end-stage inoperable patients
with calcific aortic stenosis, 698
Cardiac allograft vasculopathy
Impact of mode of donor brain death on cardiac
allograft vasculopathy, 806
Cardiac amyloidosis
Noninvasive diagnosis of biopsy-proven cardiac
amyloidosis, 410
Cardiac catheterization
CathKIT: improving quality in the cardiac
catheterization laboratory, 893
Sustained ventricular tachycardia or fibrillation in
the cardiac catheterization laboratory among
patients receiving primary percutaneous
coronary intervention, 1765
The year in congenital heart disease, 2132
Cardiac function
Glucose-insulin infusion improves cardiac function
during fetal tachycardia, 445
Understanding the impact of abnormal cardiac
activation on cardiac function (editorial), 1532
Cardiac masses
Differential diagnosis of cardiac masses using
contrast echocardiographic perfusion imaging,
1412
Masses of the heart: perfusing the “good” from the
bad (editorial), 1420
Cardiac rehabilitation
Reduction in C-reactive protein through cardiac
rehabilitation and exercise training, 1056
Cardiac resynchronization therapy
Cardiac resynchronization therapy: caveat medicus!,
1145
Effects of cardiac resynchronization therapy on left
ventricular function, myocardial energetics,
and metabolic reserve in patients with dilated
cardiomyopathy and heart failure, 1027
Pacing the left ventricle: does underlying rhythm
matter? (editorial), 239
Cardiac surgery
Impact of delays to cardiac surgery after failed
angioplasty and stenting, 337
Cardiac vagal control
Acute aldosterone antagonism improves cardiac
vagal control in humans, 1270
Cardiac volume
High-resolution transthoracic real-time three-
dimensional echocardiography: quantification
of cardiac volumes and function using semi-
automatic border detection and comparison
with cardiac magnetic resonance imaging,
2083
Cardiologists
Cardiologist’s toolbox: improving care, 2174
Platelets, the cardiologist, and coronary artery
disease: moving beyond aggregation, 1989
Cardiology
Cardiology management improves secondary
prevention measures among patients with
coronary artery disease, 1517
President’s page: strengthening our house of
cardiology, 1721
Self-referral in cardiology, 1500
Cardiomyopathy
See also Dilated cardiomyopathy; Hypertrophic
cardiomyopathy; Ischemic cardiomyopathy
Implantable cardioverter-defibrillators in patients
with arrhythmogenic right ventricular
dysplasia/cardiomyopathy, 1843
Mode of initiation and ablation of ventricular
fibrillation storms in patients with ischemic
cardiomyopathy, 1715
Cardioplegia
Ultrastructural evidence of increased tolerance of
hibernating myocardium to cardioplegic isch-
emic-reperfusion injury, 2329
Cardiopulmonary testing
Lessons from cardiopulmonary testing after device
closure of secundum atrial septal defects
(editorial), 1892
Cardiotrophin-1
Transplantation of cardiotrophin-1-expressing
myoblasts to the left ventricular wall alleviates
the transition from compensatory hypertrophy
to congestive heart failure in Dahl salt-
sensitive hypertensive rats, 2337
Cardiovascular disease
Erectile dysfunction: the earliest sign of generalized
vascular disease? (editorial), 185
Evidence-based guidelines for cardiovascular disease
prevention in women, 900
Impaired brachial artery endothelium-dependent
and -independent vasodilation in men with
erectile dysfunction and no other clinical
cardiovascular disease, 179
From knowledge to practice in chronic
cardiovascular disease: a long and winding
road, 1738
Pathophysiology of cigarette smoking and
cardiovascular disease, 1731
What is the optimal serum potassium level in
cardiovascular patients?, 155
Cardiovascular events
Relative importance of vascular structure and
function in predicting cardiovascular events,
616
Cardiovascular medicine
Paradigm shifts in cardiovascular medicine, 507
Cardiovascular surgery
Year in cardiovascular surgery, 1706
Cardioversion
Economic analysis of a transesophageal
echocardiography-guided approach to
cardioversion of patients with atrial
fibrillation, 1217
Economic implications of transesophageal
echocardiography-guided cardioversion of
atrial fibrillation (editorial), 1225
Carotid artery
Prevalence of specific variant carotid geometric
patterns and incidence of cardiovascular events
in older persons, 187
Carotid artery stenting
Intracranial hemorrhage and hyperperfusion
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syndrome following carotid artery stenting,
1596
Carotid atherosclerosis
Decreased circulating Fas ligand in patients with
familial combined hyperlipidemia or carotid
atherosclerosis, 1188
Carotid endarterectomy
Cardiologist in the carotids, 1602
Severe bilateral carotid stenosis, 1358
Carotid plaque
Echolucent carotid plaques predict future coronary
events in patients with coronary artery disease,
1177
Carotid stenting
Severe bilateral carotid stenosis, 1358
Carvedilol
Influence of pretreatment systolic blood pressure on
the effect of carvedilol in patients with severe
chronic heart failure, 1423
Predischarge initiation of carvedilol in patients
hospitalized for decompensated heart failure,
1534
Caspase
Minocycline inhibits caspase activation and
reactivation, increases the ratio of XIAP to
Smac/DIABLO, and reduces the
mitochondrial leakage of cytochrome C and
Smac/DIABLO, 865
Caspase inhibition
Long-term caspase inhibition ameliorates apoptosis,
reduces myocardial troponin-I cleavage,
protects left ventricular function, and
attenuates remodeling in rats with myocardial
infarction, 295
Catheter(s)
Electrophysiological properties of pulmonary veins
assessed using a multielectrode basket
catheter, 2281
Catheter ablation
Catheter ablation of atrial fibrillation: what is the
best technique for achieving a high cure rate
with acceptable risk?, 2054
New approach for catheter ablation of atrial
fibrillation: mapping of the
electrophysiological substrate, 2044
Catheterization
Interventional catheterization performed in the
early postoperative period after congenital
heart surgery in children, 1264
CathKIT
CathKIT: improving quality in the cardiac
catheterization laboratory, 893
CD40 ligand
Release of soluble CD40 ligand from platelets is
regulated by GP IIb/IIIa and actin
polymerization, 2319
Soluble CD40 ligand and platelets—self-
perpetuating pathogenic loop in thrombosis
and inflammation?, 2326
Cerebroprotection
Cerebroprotection mediated by angiotensin II, 1343
Cerebrovascular accidents
Characteristics of cerebrovascular accidents after
percutaneous coronary interventions, 1161
Chagas’ disease
Sympathetic nervous system activation in Chagasic
patients with congestive heart failure (letter),
1723
Chest pain
Hemoglobin level is an independent predictor of
adverse cardiovascular outcomes in women
undergoing evaluation for chest pain: results
from the NHLBI WISE study, 2009
Implication of different cardiac troponin I levels for
clinical outcomes and prognosis of acute chest
pain patients, 958
Children
Characterizing the young patient with aortic
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Prognostic value of coronary artery calcium
screening in subjects with and without
diabetes, 1663
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Diabetes mellitus: the major risk factor in unstable
coronary artery disease even after
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Treatment of multivessel coronary artery disease
with sirolimus-eluting stent implantation:
immediate and mid-term results, 1154
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Coronary flow velocity
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disease among U.S. adults, 1791
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Coronary surgery
Predictors of new malignant ventricular arrhythmias
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Coronary vascular reserve
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endotoxemic rats, 2348
Physicians
Physicians, coverage, quality, and cost: the
intertwined caduceus (commentary), 6
President’s page: continuing investment in “state-
of-the-art” physician education—an ACCF
program of high net worth, 313
U.S. healthcare: the intertwined caduceus of
physicians, coverage, quality, and cost, 1
Plaque
Accuracy of multidetector spiral computed
tomography in identifying and differentiating
the composition of coronary atherosclerotic
plaques, 1241
Echolucent carotid plaques predict future coronary
events in patients with coronary artery disease,
1177
Plaque characterization: surrogate markers or the
real thing? (editorial), 1185
Selective peroxisomal proliferator-activated
receptor-gamma agonist has an additive effect
on plaque regression in combination with
simvastatin in experimental atherosclerosis,
464
Platelets
Clopidogrel inhibits platelet-leukocyte interactions
and TRAP-induced platelet activation in
patients with an acute coronary syndrome,
1982
Inhibition of platelet aggregation by aspirin
progressively decreases in long-term treated
patients, 979
Outcome of acute ST-segment elevation myocardial
infarction in diabetics treated with fibrinolytic
or combination reduced fibrinolytic therapy
and platelet glycoprotein IIb/IIIa inhibition,
542
Platelets, the cardiologist, and coronary artery
disease: moving beyond aggregation, 1989
Release of soluble CD40 ligand from platelets is
regulated by GP IIb/IIIa and actin
polymerization, 2319
Short-term intravenous eptifibatide infusion
combined with reduced dose recombinant
tissue plasminogen activator inhibits platelet
recruitment at sites of coronary artery injury,
287
Soluble CD40 ligand and platelets—self-
perpetuating pathogenic loop in thrombosis
and inflammation?, 2326
Porcine models
Novel application of myocardial contrast
echocardiography to evaluate angiogenesis by
autologous bone marrow cell transplantation
in chronic ischemic pig model, 1299
Positron emission tomography
Myocardial positron emission computed
tomographic images obtained with fluorine-18
fluoro-2-deoxyglucose predict the response to
idiopathic dilated cardiomyopathy patients to
beta-blockers, 224
Postmortem molecular screening
Postmortem molecular screening in unexplained
sudden death, 1625
Postoperative period
Interventional catheterization performed in the
early postoperative period after congenital
heart surgery in children, 1264
Potassium
What is the optimal serum potassium level in
cardiovascular patients?, 155
Potassium channels
Autoimmunity against the second extracellular loop
of the beta1-adrenergic receptors induces early
afterdepolarization and decreases in K-channel
density in rabbits, 1090
Pravastatin
Cholesteryl ester transfer protein (CETP) TaqIB
polymorphism in the Cholesterol and
Recurrent Events Study: no interaction with
the response to pravastatin therapy and no
effects on cardiovascular outcome, 854
Preconditioning
Ischemic preconditioning in coronary heart disease:
a therapeutic golden fleece? (editorial), 1515
Prescription drugs
Drug reimportation: sitting in the middle, 149
Primary angioplasty
See also Angioplasty
Primary angioplasty in acute myocardial infarction
at hospitals with no surgery on-site (PAMI
No SOS) versus transfer to surgical centers
for primary angioplasty, 1943
Primary pulmonary hypertension
Clinical efficacy of sildenafil in primary pulmonary
hypertension, 1149
Clinical significance of brain natriuretic peptide in
primary pulmonary hypertension, 764
Prosthetic heart valves
Clinical significance of early thrombosis after
prosthetic mitral valve replacement, 1283
Early experience with percutaneous transcatheter
implantation of heart valve prosthesis for the
treatment of end-stage inoperable patients
with calcific aortic stenosis, 698
Transesophageal echocardiography improves risk
assessment of thrombolysis of prosthetic valve
thrombosis: results of the International PRO-
TEE Registry, 77
Year in valvular heart disease, 491
Pulmonary atresia
The year in congenital heart disease, 2132
Pulmonary circulation
Stenting the neonatal arterial duct in duct-
dependent pulmonary circulation: new
techniques, better results, 107
Pulmonary valve replacement
Percutaneous pulmonary valve replacement in a
large right ventricular outflow tract, 1082
Transcatheter valve replacement: a new era of
percutaneous coronary intervention begins
(editorial), 1088
Pulmonary vein isolation
Clinical significance of inducible atrial flutter
during pulmonary vein isolation in patients
with atrial fibrillation, 2057
Pulmonary vein isolation for atrial fibrillation in
low ejection fraction patients: the market is
growing (editorial), 1010
Pulmonary vein isolation for the treatment of atrial
fibrillation in patients with impaired systolic
function, 1004
Pulmonary veins
Electrophysiological properties of pulmonary veins
assessed using a multielectrode basket
catheter, 2281
Pulmonary veins in the substrate for atrial
fibrillation: the “venous wave” hypothesis
(editorial), 2290
Pulmonary venous flow
Intrauterine pulmonary venous flow and restrictive
foramen ovale in fetal hypoplastic left heart
syndrome, 1902
Pulmonary venous flow by Doppler
echocardiography: usefulness of diastolic wave
deceleration time in predicting filling pressure
(letter), 925
Pulsatile blood flow pattern
Association of a pulsatile blood flow pattern on
coronary arteriography and short-term clinical
outcomes in acute myocardial infarction, 1170
QT interval
Heart rate-corrected QT interval prolongation
predicts risk of coronary heart disease in black
and white middle-aged men and women, 565
QT interval prolongation and prognosis: further
validation of the quantitative approach to
electrocardiography (editorial), 572
Quality of life
Clinical efficacy of sildenafil in primary pulmonary
hypertension, 1149
Effect of rate or rhythm control on quality of life in
persistent atrial fibrillation, 241
Quantitative myocardial contrast echocardiography
Effects of glycoprotein IIb/IIIa inhibition on
microvascular flow after coronary reperfusion,
276
Quinidine
Short QT syndrome: pharmacological treatment,
1494
Race
See also African Americans
Impact of race on health care utilization and
outcomes in veterans with congestive heart
failure, 778
Influence of age, gender, and race on the prevalence
of depression in heart failure patients, 1542
Racial variation in the prevalence of atrial
fibrillation among patients with heart failure,
429
Racing away from bias (editorial), 785
What we’re talking about when we talk about race
(editorial), 436
Radiofrequency ablation
See also Ablation
Characteristics of virtual unipolar electrograms for
detecting isthmus block during radiofrequency
ablation of typical atrial flutter, 2300
Endocardial and epicardial radiofrequency ablation
of ventricular tachycardia associated with
dilated cardiomyopathy, 1834
Functional characterization of the crista terminalis
in patients with atrial flutter: implications for
radiofrequency ablation, 1639
Radiofrequency catheter ablation of type 1 atrial
flutter using large-tip 8- or 10-mm electrode
catheters and a high-output radiofrequency
energy generator, 1466
Ramipril
Effects of ramipril on left ventricular mass and
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function in cardiovascular patients with
controlled blood pressure and with preserved
left ventricular ejection fraction, 2200
Ranolazine
Anti-ischemic effects and long-term survival during
ranolazine monotherapy in patients with
chronic severe angina, 1375
Reactive hyperemia
Reactive hyperemia as a test of endothelial or
microvascular function? (letter), 2147
Reactive oxygen species
Comparative effects of valsartan versus amlodipine
on left ventricular mass and reactive oxygen
species formation by monocytes in
hypertensive patients with left ventricular
hypertrophy, 2116
Rehabilitation
Reduction in C-reactive protein through cardiac
rehabilitation and exercise training, 1056
Remodeling
Angina pectoris prior to myocardial infarction
protects against subsequent left ventricular
remodeling, 1511
Angiotensin receptor blockade improves myocardial
beta-adrenergic receptor signaling in postinfarc-
tion left ventricular remodeling, 125
Assessment of coronary remodeling in stenotic and
nonstenotic coronary atherosclerotic lesions by
multidetector spiral computed tomography,
842
Cardiac atria are chambers of active remodeling and
dynamic collagen turnover during evolving
heart failure, 68
Doppler-derived mitral deceleration time as a
strong prognostic marker of left ventricular
remodeling and survival after acute myocardial
infarction, 1646
Infarct resorption, compensatory hypertrophy, and
differing patterns of ventricular remodeling
following myocardial infarctions of varying
size, 2124
Ischemic mitral regurgitation and ventricular
remodeling (editorial), 384
Long-term caspase inhibition ameliorates apoptosis,
reduces myocardial troponin-I cleavage,
protects left ventricular function, and
attenuates remodeling in rats with myocardial
infarction, 295
Prevention of ischemic mitral regurgitation does
not influence the outcome of remodeling after
posterolateral myocardial infarction, 377
Severity of left ventricular remodeling defines
outcomes and response to therapy in heart
failure: Val-HeFT echocardiography data,
2022
Renal artery stenosis
Profile of cardiac patients with renal artery stenosis,
1606
Renal artery stenosis: “fortuitous diagnosis,”
problematic therapy (editorial), 1614
Renal function
Incidence, predictors at admission, and impact of
worsening renal function among patients
hospitalized with heart failure, 61
Reperfusion
Primary percutaneous coronary intervention at
hospitals without on-site cardiac surgery:
expanding the use of mechanical reperfusion
for acute myocardial infarction (editorial),
1951
Transient and reversible deoxyribonucleic acid
damage in human left ventricle under
controlled ischemia and reperfusion, 1992
Reperfusion therapy
Impact of intravenous beta-blockade before primary
angioplasty on survival in patients undergoing
mechanical reperfusion therapy for acute
myocardial infarction, 1780
Randomized trial comparing myocardial salvage
achieved by coronary stenting versus balloon
angioplasty in patients with acute myocardial
infarction considered ineligible for reperfusion
therapy, 734
Research
Eptifibatide provides additional platelet inhibition
in non–ST-elevation myocardial infarction
patients already treated with aspirin and
clopidogrel, 162
Optimal glycemic control is associated with a lower
rate of target vessel revascularization in treated
type II diabetic patients undergoing elective
percutaneous coronary intervention, 8
Restenosis
See also Stenosis
Can we afford to eliminate restenosis?, 513
Cutting balloon versus conventional balloon
angioplasty for the treatment of in-stent resten-
osis, 949
Evaluation of the effect of oral verapamil on clinical
outcome and angiographic restenosis after
percutaneous coronary intervention, 2160
Heme oxygenase-1 genotype and restenosis after
balloon angioplasty: a novel protective factor,
950
Highlights of the 2003 Transcatheter
Cardiovascular Therapeutics annual meeting:
clinical implications, 684
Monocyte: the key in the lock to reduce stent
hyperplasia? (editorial), 24
Optimization of glycemic control and restenosis
prevention in diabetic patients undergoing
percutaneous coronary interventions
(editorial), 15
Significant reduction in restenosis following the use
of sirolimus-eluting stents in the treatment of
chronic total occlusions, 1954
Revascularization
Diabetes mellitus: the major risk factor in unstable
coronary artery disease even after
consideration of the extent of coronary artery
disease and revascularization, 585
Optimal glycemic control is associated with a lower
rate of target vessel revascularization in treated
type II diabetic patients undergoing elective
percutaneous coronary intervention, 8
Rheumatic mitral stenosis
Dobutamine stress echocardiography for
noninvasive assessment and risk stratification
of patients with rheumatic mitral stenosis, 393
Right atrium
Expression of angiotensin II receptors in human
left and right atrial tissue in atrial fibrillation
with and without underlying mitral valve
disease (letter), 2363
Right ventricle
Acute comparative effect of right and left
ventricular pacing in patients with permanent
atrial fibrillation, 234
Left ventricular mechanics during right ventricular
apical or left ventricular-based pacing in
patients with chronic atrial fibrillation after
atrioventricular junction ablation, 1013
Molecular normalization of dystrophin in the
failing left and right ventricle of patients
treated with either pulsatile or continuous
flow-type ventricular assist devices, 811
Systemic ventricular function in patients with
transposition of the great arteries after atrial
repair: a tissue Doppler and conductance
catheter study, 100
Right ventricular outflow tract
Percutaneous pulmonary valve replacement in a
large right ventricular outflow tract, 1082
Risk assessment and stratification
B-type natriuretic peptide and peak exercise oxygen
consumption provide independent information
for risk stratification in patients with stable
congestive heart failure, 1584
Cardiovascular risk reduction in hypertensive black
patients with left ventricular hypertrophy,
1047
Catheter ablation of atrial fibrillation: what is the
best technique for achieving a high cure rate
with acceptable risk?, 2054
Clinical and echocardiographic score for assigning
risk of major events after dobutamine
echocardiograms, 2102
Dobutamine stress echocardiography for
noninvasive assessment and risk stratification
of patients with rheumatic mitral stenosis, 393
Effect of sleep loss on C-reactive protein, an
inflammatory marker of cardiovascular risk,
678
Heart disease risk factors predict erectile
dysfunction 25 years later, 1405
Heart rate-corrected QT interval prolongation
predicts risk of coronary heart disease in black
and white middle-aged men and women, 565
Increased left ventricular mass is a risk factor for
the development of a depressed left ventricular
ejection fraction within five years: the
Cardiovascular Health Study, 2207
Nonsteroidal anti-inflammatory drugs and
cardiovascular risk, 519
Predischarge B-type natriuretic peptide assay for
identifying patients at high risk of re-
admission after decompensated heart failure,
635
Reverse epidemiology of conventional cardiovascular
risk factors in patients with chronic heart
failure, 1439
Risk of noncardiac surgery in the months following
placement of a drug-eluting coronary stent
(letter), 713
Risk stratification using stress myocardial perfusion
imaging: don’t neglect the value of clinical
variables (editorial), 209
Stress myocardial perfusion single-photon emission
computed tomography is clinically effective
and cost effective in risk stratification of
patients with a high likelihood of coronary
artery disease (CAD) but no known CAD,
200
Transesophageal echocardiography improves risk
assessment of thrombolysis of prosthetic valve
thrombosis: results of the International PRO-
TEE Registry, 77
Triglyceride-rich lipoprotein remnant levels and
metabolism: time to adopt these orphan risk
factors?, 2233
Risk factors
Assessing low levels of high-density lipoprotein
cholesterol as a risk factor in coronary heart
disease, 717
Diabetes mellitus: the major risk factor in unstable
coronary artery disease even after
consideration of the extent of coronary artery
disease and revascularization, 585
Novel and traditional cardiovascular risk factors in
children with Kawasaki disease, 120
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Rostral ventrolateral medulla
Relationship to neurovascular compression to
central sympathetic discharge and essential
hypertension, 1453
Saphenous vein graft
Severe ostial saphenous vein graft disease leading to
acute coronary syndromes following proximal
aorto-saphenous anastomoses with the
Symmetry Bypass Connector device, 133
Scar thickness
Impact of scar thickness on the assessment of
viability using dobutamine echocardiography
and thallium single-photon emission
computed tomography, 1248
Screenings
Cost-effectiveness of screening with B-type
natriuretic peptide to identify patients with
reduced left ventricular ejection fraction, 1019
Postmortem molecular screening in unexplained
sudden death, 1625
Prognostic value of coronary artery calcium
screening in subjects with and without
diabetes, 1663
Shocks
Filling the need for new antiarrhythmic drugs to
prevent shocks from implantable cardioverter
defibrillators (editorial), 44
Short QT syndrome
Short QT syndrome: pharmacological treatment,
1494
Shunts
Transcatheter closure of atrial shunts (editorial),
310
Sick sinus syndrome
Predictors of stroke in patients paced for sick sinus
syndrome, 1617
Single lead ventricular pacing is no longer an
option for sick sinus syndrome, 2072
Sildenafil
Clinical efficacy of sildenafil in primary pulmonary
hypertension, 1149
Time course of the interaction between tadalafil
and nitrates (letter), 2150
Simvastatin
Selective peroxisomal proliferator-activated
receptor-gamma agonist has an additive effect
on plaque regression in combination with
simvastatin in experimental atherosclerosis,
464
Single-photon emission computed tomography
See also Computed tomography
Assessment of the physiologic significance of
coronary disease with dipyridamole real-time
myocardial contrast echocardiography, 257
Impact of scar thickness on the assessment of
viability using dobutamine echocardiography
and thallium single-photon emission
computed tomography, 1248
Incremental value of parametric quantitative
assessment of myocardial perfusion by
triggered low-power myocardial contrast
echocardiography, 1807
Risk stratification using stress myocardial perfusion
imaging: don’t neglect the value of clinical
variables (editorial), 209
Stress myocardial perfusion single-photon emission
computed tomography is clinically effective
and cost effective in risk stratification of
patients with a high likelihood of coronary
artery disease (CAD) but no known CAD,
200
Technetium 99m sestamibi myocardial perfusion
imaging predicts clinical outcome in the
community outpatient setting, 213
Sinus node dysfunction
High incidence of pacemaker syndrome in patients
with sinus node dysfunction treated with
VVIR pacing in MOST, 2066
Sirolimus-eluting stents
Canadian study of the sirolimus-eluting stent in the
treatment of patients with long de novo
lesions in small native coronary arteries (C-
SIRIUS), 1110
Impact of final stent dimensions on long-term
results following sirolimus-eluting stent
implantation, 1959
Short- and long-term clinical benefit of sirolimus-
eluting stents compared to conventional bare
stents for patients with acute myocardial infarc-
tion, 704
Significant reduction in restenosis following the use
of sirolimus-eluting stents in the treatment of
chronic total occlusions, 1954
Sirolimus-eluting stents: does a great stent still
need a good interventionalist (editorial), 1116
Treatment of multivessel coronary artery disease
with sirolimus-eluting stent implantation:
immediate and mid-term results, 1154
Sleep deprivation
Effect of sleep loss on C-reactive protein, an
inflammatory marker of cardiovascular risk,
678
Smac/DIABLO
Minocycline inhibits caspase activation and
reactivation, increases the ratio of XIAP to
Smac/DIABLO, and reduces the
mitochondrial leakage of cytochrome C and
Smac/DIABLO, 865
Smallpox
Smallpox vaccination and myopericarditis: a clinical
review, 1503
Smoking
Pathophysiology of cigarette smoking and
cardiovascular disease, 1731
Statins
Statin therapy is associated with improved survival
in ischemic and non-ischemic heart failure,
642
Statins to reduce risk of depression (letter), 1132
Stenosis
See also Restenosis
Accuracy of dipyridamole myocardial contrast
echocardiography for the detection of residual
stenosis of the infarct related artery and
multivessel disease early after acute myocardial
infarction, 2247
Assessment of coronary remodeling in stenotic and
nonstenotic coronary atherosclerotic lesions by
multidetector spiral computed tomography,
842
Profile of cardiac patients with renal artery stenosis,
1606
Real-time three-dimensional echocardiography for
rheumatic mitral valve stenosis evaluation: an
accurate and novel approach, 2091
Renal artery stenosis: “fortuitous diagnosis,”
problematic therapy (editorial), 1614
Severe bilateral carotid stenosis, 1358
Stents and stenting
Can we afford to eliminate restenosis?, 513
Canadian study of the sirolimus-eluting stent in the
treatment of patients with long de novo
lesions in small native coronary arteries (C-
SIRIUS), 1110
Circulating monocytes and in-stent neointima after
coronary stent implantation, 18
Combined stenting versus balloon angioplasty in
small vessels, 1964
Don’t blame the stents (editorial), 1355
First human experience with the 17-beta-estradiol–
eluting stent, 1118
Highlights of the 2003 Transcatheter
Cardiovascular Therapeutics annual meeting:
clinical implications, 684
For how long should treatment with clopidogrel be
continued after coronary stent implantation
(letter), 1331
Impact of delays to cardiac surgery after failed
angioplasty and stenting, 337
Impact of final stent dimensions on long-term
results following sirolimus-eluting stent
implantation, 1959
Intracranial hemorrhage and hyperperfusion
syndrome following carotid artery stenting,
1596
Randomized trial comparing myocardial salvage
achieved by coronary stenting versus balloon
angioplasty in patients with acute myocardial
infarction considered ineligible for reperfusion
therapy, 734
Risk of noncardiac surgery in the months following
placement of a drug-eluting coronary stent
(letter), 713
Severe bilateral carotid stenosis, 1358
Short- and long-term clinical benefit of sirolimus-
eluting stents compared to conventional bare
stents for patients with acute myocardial infarc-
tion, 704
Short- and long-term results after multivessel
stenting in diabetic patients, 1348
Significant reduction in restenosis following the use
of sirolimus-eluting stents in the treatment of
chronic total occlusions, 1954
Sirolimus-eluting stents: does a great stent still
need a good interventionalist (editorial), 1116
Stenting the neonatal arterial duct in duct-
dependent pulmonary circulation: new
techniques, better results, 107
Treatment of multivessel coronary artery disease
with sirolimus-eluting stent implantation:
immediate and mid-term results, 1154
Year in interventional cardiology, 875
Sternotomy
Comparison of short- and long-term outcomes
after off-pump and on-pump coronary artery
bypass graft surgery with sternotomy, 557
Streptococcus viridans endocarditis
Embolic complications in Streptococcus viridans
endocarditis (letter), 1133
Stress echocardiography
Clinical and echocardiographic score for assigning
risk of major events after dobutamine
echocardiograms, 2102
Dobutamine stress echocardiography for
noninvasive assessment and risk stratification
of patients with rheumatic mitral stenosis, 393
Impact of scar thickness on the assessment of
viability using dobutamine echocardiography
and thallium single-photon emission
computed tomography, 1248
Stress echocardiography in mitral stenosis: when is
it useful? (editorial), 402
Stress myocardial perfusion imaging
Risk stratification using stress myocardial perfusion
imaging: don’t neglect the value of clinical
variables (editorial), 209
Stress myocardial perfusion single-photon emission
computed tomography is clinically effective
and cost effective in risk stratification of
patients with a high likelihood of coronary
artery disease (CAD) but no known CAD,
200
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Stress testing
Akinesia becoming dyskinesia after exercise testing:
prevalence and relationship to clinical
outcome, 599
Treadmill scores in elderly men, 606
Stroke
Characteristics of cerebrovascular accidents after
percutaneous coronary interventions, 1161
Chronologic distribution of stroke after minimally
invasive versus conventional coronary artery
bypass, 752
Comparing the guidelines: anticoagulation therapy
to optimize stroke prevention in patients with
atrial fibrillation, 929
Predictors of stroke in patients paced for sick sinus
syndrome, 1617
Stroke after percutaneous coronary interventions
(editorial), 1168
Stroke and pacing mode: is pacing mode
important? (editorial), 1623
ST-segment
Improved speed and stability of ST-segment
recovery with reduced-dose tenecteplase and
eptifibatide compared with full-dose
tenecteplase for acute ST-segment elevation
myocardial infarction, 549
ST-segment elevation myocardial infarction
Improved speed and stability of ST-segment
recovery with reduced-dose tenecteplase and
eptifibatide compared with full-dose
tenecteplase for acute ST-segment elevation
myocardial infarction, 549
Outcome of acute ST-segment elevation myocardial
infarction in diabetics treated with fibrinolytic
or combination reduced fibrinolytic therapy
and platelet glycoprotein IIb/IIIa inhibition,
542
Rationale and strategies for implementing
community-based transfer protocols for
primary percutaneous coronary intervention
for acute ST-segment elevation myocardial
infarction, 2153
Stunned myocardium
Calcium sensitizer levosimendan improves the
function of stunned myocardium after
percutaneous transluminal coronary
angioplasty in acute myocardial ischemia,
2177
Sudden cardiac death
Analysis of mortality events in the Multicenter
Automatic Defibrillator Implantation Trial
(MADIT-II), 1459
Long-term subthreshold electrical stimulation of
the left stellate ganglion and a canine model
of sudden cardiac death, 858
Natriuretic peptides as predictors of non-sudden
and sudden cardiac death after acute
myocardial infarction in the beta-blocking era,
757
Postmortem molecular screening in unexplained
sudden death, 1625
Sudden death in patients without structural heart
disease, 1137
Surgery
See also Ablation; Cardiac surgery; Coronary artery
bypass grafting; Radiofrequency ablation
Predictors of new malignant ventricular arrhythmias
after coronary surgery, 1630
Surgery, angioplasty, or medical therapy for
symptomatic multivessel coronary artery
disease (editorial), 1752
Year in cardiovascular surgery, 1706
Symmetry Bypass Connector
Severe ostial saphenous vein graft disease leading to
acute coronary syndromes following proximal
aorto-saphenous anastomoses with the
Symmetry Bypass Connector device, 133
Sympathetic nervous system
Sympathetic nervous system activation in Chagasic
patients with congestive heart failure (letter),
1723
Systolic blood pressure
Influence of pretreatment systolic blood pressure on
the effect of carvedilol in patients with severe
chronic heart failure, 1423
Mechanism(s) of selective systolic blood pressure
reduction after low-dose combination of
perindopril/indapamide in hypertensive
subjects: comparison with atenolol, 92
Systolic function
Patients with a hypertensive response to exercise
have impaired systolic function without
diastolic dysfunction or left ventricular
hypertrophy, 848
Pulmonary vein isolation for the treatment of atrial
fibrillation in patients with impaired systolic
function, 1004
Systolic heart failure
Angiotensin-converting enzyme inhibitors, beta-
blockers, and mortality in systolic heart failure
(letter), 1333
Plasma B-type natriuretic peptide levels in systolic
heart failure, 416
T cells
Neoangiogenesis, T-lymphocyte infiltration, and
heat shock protein-60 are biological hallmarks
of an immunomediated inflammatory process
in end-stage calcified aortic valve stenosis,
1670
Tachyarrhythmias
Azimilide decreases recurrent ventricular
tachyarrhythmias in patients with implantable
cardioverter defibrillators, 39
Tachycardia
See also Atrial tachycardia; Ventricular tachycardia
Clinical course of atrial ectopic tachycardia is age-
dependent: results and treatment in children 3
or 3 years of age, 438
Glucose-insulin infusion improves cardiac function
during fetal tachycardia, 445
Tadalafil
Time course of the interaction between tadalafil
and nitrates (letter), 2150
Technetium-99m sestamibi
Assessment of the physiologic significance of
coronary disease with dipyridamole real-time
myocardial contrast echocardiography, 257
Technetium 99m sestamibi myocardial perfusion
imaging predicts clinical outcome in the
community outpatient setting, 213
Tenecteplase
Improved speed and stability of ST-segment
recovery with reduced-dose tenecteplase and
eptifibatide compared with full-dose
tenecteplase for acute ST-segment elevation
myocardial infarction, 549
Tetralogy of Fallot
Factors associated with impaired clinical status in
long-term survivors of tetralogy of Fallot
repair evaluated by magnetic resonance
imaging, 1068
The year in congenital heart disease, 2132
Thallium single-photon emission computed
tomography
Impact of scar thickness on the assessment of
viability using dobutamine echocardiography
and thallium single-photon emission
computed tomography, 1248
Thrombin receptor agonist peptide
Clopidogrel inhibits platelet-leukocyte interactions
and TRAP-induced platelet activation in
patients with an acute coronary syndrome,
1982
Thrombolysis In Myocardial Infarction flow
Preprocedural TIMI flow and mortality in patients
with acute myocardial infarction treated by
primary angioplasty, 1363
Thrombosis
Clinical significance of early thrombosis after
prosthetic mitral valve replacement, 1283
Soluble CD40 ligand and platelets—self-
perpetuating pathogenic loop in thrombosis
and inflammation?, 2326
Transesophageal echocardiography improves risk
assessment of thrombolysis of prosthetic valve
thrombosis: results of the International PRO-
TEE Registry, 77
Thromboxane A2
Optimal suppression of thromboxane A2 formation
by aspirin during percutaneous transluminal
coronary angioplasty: no additional effect of a
selective cyclooxygenase-2 inhibitor, 526
Thrombus
Incidence and clinical course of thrombus formation
on atrial septal defect and patent foramen
ovale closure devices in 1,000 consecutive
patients, 302
Left atrial thrombus associated with ablation for
atrial fibrillation: identification with
intracardiac echocardiography, 1861
Thymidine kinase
Powerful and controllable angiogenesis by using
gene-modified cells expressing human
hepatocyte growth factor and thymidine
kinase, 1915
Tissue Doppler imaging
Noninvasive estimation of left ventricular filling
pressure by E/e’ is a powerful predictor of
survival after acute myocardial infarction, 360
Systemic ventricular function in patients with
transposition of the great arteries after atrial
repair: a tissue Doppler and conductance
catheter study, 100
Tissue Doppler imaging predicts recovery of left
ventricular function after recanalization of an
occluded coronary artery, 85
Tissue plasminogen activator
Short-term intravenous eptifibatide infusion
combined with reduced dose recombinant
tissue plasminogen activator inhibits platelet
recruitment at sites of coronary artery injury,
287
Training
Training cardiovascular fellows in cardiovascular
magnetic resonance and vascular imaging:
current status following the Core
Cardiovascular Training Symposium
(COCATS-2) guidelines, 2108
Transesophageal echocardiography
Economic analysis of a transesophageal
echocardiography-guided approach to
cardioversion of patients with atrial
fibrillation, 1217
Economic implications of transesophageal
echocardiography-guided cardioversion of
atrial fibrillation (editorial), 1225
Transesophageal echocardiography improves risk
assessment of thrombolysis of prosthetic valve
thrombosis: results of the International PRO-
TEE Registry, 77
Transmyocardial revascularization
From controlled trials to clinical practice:
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transmyocardial revascularization use and
outcomes (letter), 2364
Transplantation
Angiotensin II receptors from peritransplantation
through first-year post-transplantation and the
risk of transplant coronary artery disease, 1565
Frequency and impact of delayed decisions
regarding heart transplantation on long-term
outcomes in patients with advanced heart
failure, 794
Glucose intolerance as reflected by hemoglobin A1c
level, is associated with the incidence and
severity of transplant coronary artery disease,
1034
Heart transplantation: the increasing challenges of
evidence-based decision-making (editorial),
803
Novel application of myocardial contrast
echocardiography to evaluate angiogenesis by
autologous bone marrow cell transplantation
in chronic ischemic pig model, 1299
Selection of patients for heart transplantation in the
current era of heart failure therapy, 787
Transplantation of cardiotrophin-1-expressing
myoblasts to the left ventricular wall alleviates
the transition from compensatory hypertrophy
to congestive heart failure in Dahl salt-
sensitive hypertensive rats, 2337
Transposition of the great arteries
Outcome of patients with double-inlet left ventricle
or tricuspid atresia with transposed great
arteries, 113
Systemic ventricular function in patients with
transposition of the great arteries after atrial
repair: a tissue Doppler and conductance
catheter study, 100
The year in congenital heart disease, 2132
Transthoracic Doppler echocardiography
Enhanced coronary flow velocity during intra-aortic
balloon pumping assessed by transthoracic
Doppler echocardiography, 368
Transthoracic echocardiography
High-resolution transthoracic real-time three-
dimensional echocardiography: quantification
of cardiac volumes and function using semi-
automatic border detection and comparison
with cardiac magnetic resonance imaging,
2083
Tricuspid atresia
Outcome of patients with double-inlet left ventricle
or tricuspid atresia with transposed great
arteries, 113
Tricuspid regurgitation
Impact of tricuspid regurgitation on long-term
survival, 405
Triglyceride lipolysis
Impaired intravascular triglyceride lipolysis
constitutes a marker of clinical outcome in
patients with stable angina under secondary
prevention treatment: a long-term follow-up,
2225
Triglycerides
Triglyceride-rich lipoprotein remnant levels and
metabolism: time to adopt these orphan risk
factors?, 2233
Troponin-I
Implication of different cardiac troponin I levels for
clinical outcomes and prognosis of acute chest
pain patients, 958
Long-term caspase inhibition ameliorates apoptosis,
reduces myocardial troponin-I cleavage,
protects left ventricular function, and
attenuates remodeling in rats with myocardial
infarction, 295
Tumor necrosis factor-
Hydroxyl radical generation, levels of tumor
necrosis factor- and progression to heart
failure after acute myocardial infarction, 2000
Ultrasound
See Intravascular ultrasound
Unfractionated heparin
Administration of eptifibatide to acute coronary
syndrome patients receiving enoxaparin or
unfractionated heparin, 966
Unstable angina
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